High Vitamin K Intake Diet Intervention Effect on Cardiovascular Risk Percentage in Young Adults
VKDI
Effect of Dietary Intervention With a High Intake of Vitamin K on Insulin, Osteocalcin, Leptin, Vitamin K Serum Levels and Cardiovascular Risk in Young Adults With and Without Overweight or Obesity.
2 other identifiers
interventional
72
1 country
1
Brief Summary
The goal of this clinical trial is to compare the effect of a high vitamin K diet intervention on vitamin K, insulin, osteocalcin serum levels and the cardiovascular risk percentage in normal weight and overweight or obese young adults. The main questions it aims to answer are: • Does a diet intervention containing 500mcg of vitamin K increases serum vitamin K levels? • Are vitamin K serum levels after the 500mcg of vitamin K diet intervention associated with insulin and osteocalcin serum levels or the cardiovascular risk percentage in normal weight and overweight or obese young adults? Participants will have to follow a diet intervention that contains 500mcg of vitamin K, given as a cyclic menu for 6 weeks. Also, participants will have to assist weekly to nutritional monitoring and to report any situation they observed regarding the intervention during this study. Researchers will compare normal weight and overweight or obese groups with diet intervention with normal weight and overweight or obese groups without diet intervention and only dietetic recommendations to see if vitamin K serum levels, insulin, osteocalcin and the cardiovascular risk percentage improve after the 6 weeks diet intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 6, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 12, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
August 16, 2021
CompletedFirst Submitted
Initial submission to the registry
November 27, 2023
CompletedFirst Posted
Study publicly available on registry
February 9, 2024
CompletedFebruary 9, 2024
February 1, 2024
5 months
November 27, 2023
February 6, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
vitamin K serum levels
ng/mL
basal and after 6 weeks of diet intervention
Cardiovascular Risk Percentage
percentage (%)
basal and after 6 weeks of diet intervention
insulin serum levels
mcUI/L
basal and after 6 weeks of diet intervention
Secondary Outcomes (1)
Osteocalcin
basal and after 6 weeks of diet intervention
Study Arms (2)
VK INTERVENTION
EXPERIMENTALadministration of a menu diet containing 500mcg of vitamin K (in the food selected) durinf 6 weeks.
DIETARY RECOMMENDATIONS
NO INTERVENTIONNo menu administration but only recommendations for correct diet.
Interventions
500mcg of Vitamin K intake provided by the selection of vitamin k rich foods in the menu.
Eligibility Criteria
You may qualify if:
- young adults
- acceptation for participate
- acceptation to asist to monitoring sessions
- sign information consent
You may not qualify if:
- under other dietetic intervention
- under medications that interfere with vitamin K or diminish its absorbtion
- vitamin E or A intake supplements
- previous diagnose of metabolic syndrome, diabetes mellitus, hypertension, cancer or dyslipidemia.
- chronic alcohol intake
- some medical or health situation that impedes the following of the program
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centro Universitario de Ciencias de la Salud
Guadalajara, Jalisco, 44340, Mexico
Related Publications (7)
Chen HG, Sheng LT, Zhang YB, Cao AL, Lai YW, Kunutsor SK, Jiang L, Pan A. Association of vitamin K with cardiovascular events and all-cause mortality: a systematic review and meta-analysis. Eur J Nutr. 2019 Sep;58(6):2191-2205. doi: 10.1007/s00394-019-01998-3. Epub 2019 May 22.
PMID: 31119401BACKGROUNDSimes DC, Viegas CSB, Araujo N, Marreiros C. Vitamin K as a Diet Supplement with Impact in Human Health: Current Evidence in Age-Related Diseases. Nutrients. 2020 Jan 3;12(1):138. doi: 10.3390/nu12010138.
PMID: 31947821BACKGROUNDVera-Remartinez EJ, Lazaro Monge R, Granero Chinesta S, Sanchez-Alcon Rodriguez D, Planelles Ramos MV. [Cardiovascular risk factors in young adults of a penitentiary center]. Rev Esp Salud Publica. 2018 Jul 6;92:e201807037. Spanish.
PMID: 29978853BACKGROUNDShea MK, Booth SL, Weiner DE, Brinkley TE, Kanaya AM, Murphy RA, Simonsick EM, Wassel CL, Vermeer C, Kritchevsky SB; Health ABC Study. Circulating Vitamin K Is Inversely Associated with Incident Cardiovascular Disease Risk among Those Treated for Hypertension in the Health, Aging, and Body Composition Study (Health ABC). J Nutr. 2017 May;147(5):888-895. doi: 10.3945/jn.117.249375. Epub 2017 Mar 29.
PMID: 28356433BACKGROUNDYoshida M, Booth SL, Meigs JB, Saltzman E, Jacques PF. Phylloquinone intake, insulin sensitivity, and glycemic status in men and women. Am J Clin Nutr. 2008 Jul;88(1):210-5. doi: 10.1093/ajcn/88.1.210.
PMID: 18614743BACKGROUNDAl-Suhaimi EA, Al-Jafary MA. Endocrine roles of vitamin K-dependent- osteocalcin in the relation between bone metabolism and metabolic disorders. Rev Endocr Metab Disord. 2020 Mar;21(1):117-125. doi: 10.1007/s11154-019-09517-9.
PMID: 31761961BACKGROUNDGaona-Pineda EB, Martinez-Tapia B, Arango-Angarita A, Valenzuela-Bravo D, Gomez-Acosta LM, Shamah-Levy T, Rodriguez-Ramirez S. [Food groups consumption and sociodemographic characteristics in Mexican population]. Salud Publica Mex. 2018 May-Jun;60(3):272-282. doi: 10.21149/8803. Spanish.
PMID: 29746744RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Iris M Llamas-Covarrubias, PhD
University of Guadalajara
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 27, 2023
First Posted
February 9, 2024
Study Start
February 6, 2021
Primary Completion
July 12, 2021
Study Completion
August 16, 2021
Last Updated
February 9, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- 6 months after publication
- Access Criteria
- IPD will be shared by email request after the request review by the main researcher
IPD that underlie results in a publication